FI49290C - Menetelmä uusien terapeuttisesti käyttökelpoisten benseenijohdannaiste n valmistamiseksi. - Google Patents

Menetelmä uusien terapeuttisesti käyttökelpoisten benseenijohdannaiste n valmistamiseksi.

Info

Publication number
FI49290C
FI49290C FI683649A FI364968A FI49290C FI 49290 C FI49290 C FI 49290C FI 683649 A FI683649 A FI 683649A FI 364968 A FI364968 A FI 364968A FI 49290 C FI49290 C FI 49290C
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
benzene derivatives
new therapeutically
useful benzene
Prior art date
Application number
FI683649A
Other languages
English (en)
Swedish (sv)
Other versions
FI49290B (fi
Inventor
Kenneth Robert Harry Wooldridge
Berkeley Basil
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Application granted granted Critical
Publication of FI49290B publication Critical patent/FI49290B/fi
Publication of FI49290C publication Critical patent/FI49290C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53Nitrogen atoms
    • AHUMAN NECESSITIES
    • A63SPORTS; GAMES; AMUSEMENTS
    • A63FCARD, BOARD, OR ROULETTE GAMES; INDOOR GAMES USING SMALL MOVING PLAYING BODIES; VIDEO GAMES; GAMES NOT OTHERWISE PROVIDED FOR
    • A63F3/00Board games; Raffle games
    • A63F3/04Geographical or like games ; Educational games
    • A63F3/0415Number games
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72Hydrazones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46Oxygen atoms
    • C07D213/50Ketonic radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D303/00Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02Compounds containing oxirane rings
    • C07D303/12Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/24Ethers with hydroxy compounds containing no oxirane rings with polyhydroxy compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Algebra (AREA)
  • General Physics & Mathematics (AREA)
  • Mathematical Analysis (AREA)
  • Pure & Applied Mathematics (AREA)
  • Educational Technology (AREA)
  • Multimedia (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI683649A 1967-12-22 1968-12-18 Menetelmä uusien terapeuttisesti käyttökelpoisten benseenijohdannaiste n valmistamiseksi. FI49290C (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB5851667 1967-12-22
GB5651368 1968-05-14
GB37103/68A GB1247384A (en) 1967-12-22 1968-08-02 Benzene derivatives

Publications (2)

Publication Number Publication Date
FI49290B FI49290B (fi) 1975-01-31
FI49290C true FI49290C (fi) 1975-05-12

Family

ID=27259415

Family Applications (1)

Application Number Title Priority Date Filing Date
FI683649A FI49290C (fi) 1967-12-22 1968-12-18 Menetelmä uusien terapeuttisesti käyttökelpoisten benseenijohdannaiste n valmistamiseksi.

Country Status (14)

Country Link
US (1) US3726919A (fi)
CY (1) CY723A (fi)
DE (1) DE1815808C3 (fi)
DK (1) DK129034B (fi)
ES (1) ES361741A1 (fi)
FI (1) FI49290C (fi)
GB (1) GB1247384A (fi)
IE (1) IE32898B1 (fi)
IL (1) IL31299A (fi)
MY (1) MY7400060A (fi)
NL (1) NL169172C (fi)
SE (1) SE357197B (fi)
YU (1) YU35873B (fi)
ZA (1) ZA6808345B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3857952A (en) * 1967-12-22 1974-12-31 May & Baker Ltd Certain benzene derivatives useful in treating cardiac disorders
US3959359A (en) * 1968-01-23 1976-05-25 Laboratoires Laroche Navarron Phenoxyalkylamines, process for their preparation and therapeutical composition containing same
US4046913A (en) * 1973-08-18 1977-09-06 Boehringer Ingelheim Gmbh 1-(M-alkanoyloxy-phenyl)-1-hydroxy-2-(N-lower alkyl-amino)-ethanes and salts thereof
FI65987C (fi) * 1973-12-12 1984-08-10 Ici Ltd Foerfarande foer framstaellning av nya terapeutiskt anvaendbara alkanolaminderivat
DE2948056A1 (de) * 1979-11-29 1981-06-04 Boehringer Mannheim Gmbh, 6800 Mannheim Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
FI832377A0 (fi) * 1983-06-29 1983-06-29 Star Oy Ab Nytt foerfarande foer framstaellning av (r)-, (s)-eller (r,s)-1-(4'-alkylamido-2'-acetyl) fenoxi-3-alkylamino-2-propanoler
FR2647449B1 (fr) * 1989-05-23 1994-03-25 Rhone Poulenc Sante Procede de preparation d'ethers aromatiques
US5661138A (en) * 1996-10-03 1997-08-26 Clarion Pharmaceutical, Inc. (o-Acyl-p-N-acylamino-phenyl)-O-phosphoethanolamines
ATE330633T1 (de) * 2000-07-27 2006-07-15 Pharmacia Corp Epoxy-steroidaler aldosteronantagonist und beta- adrenergischer antagonist-kombinationstherapie zur behandlung von kongestivem herzversagen
RU2006133300A (ru) * 2004-02-17 2008-03-27 Президент Энд Феллоуз Оф Гарвард Колледж (Us) Управление течением офтальмологических расстройств, включая дегенерацию желтого пятна
US7566808B2 (en) * 2004-02-17 2009-07-28 President And Fellows Of Harvard College Management of ophthalmologic disorders, including macular degeneration
CN102241603A (zh) * 2010-05-10 2011-11-16 中国科学院理化技术研究所 R-或s-醋丁洛尔的不对称合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1078852A (en) * 1964-09-30 1967-08-09 Ici Ltd Alkanolamine derivatives

Also Published As

Publication number Publication date
YU301968A (en) 1980-12-31
NL6818289A (fi) 1969-06-24
MY7400060A (en) 1974-12-31
GB1247384A (en) 1971-09-22
SE357197B (fi) 1973-06-18
FI49290B (fi) 1975-01-31
ES361741A1 (es) 1970-12-01
IE32898L (en) 1969-06-22
YU35873B (en) 1981-08-31
IL31299A0 (en) 1969-02-27
CY723A (en) 1974-02-16
ZA6808345B (en)
IE32898B1 (en) 1974-01-09
NL169172C (nl) 1982-06-16
DE1815808C3 (de) 1980-02-21
US3726919A (en) 1973-04-10
IL31299A (en) 1972-09-28
NL169172B (nl) 1982-01-18
DK129034B (da) 1974-08-12
DE1815808B2 (de) 1979-05-31
DE1815808A1 (de) 1970-02-26

Similar Documents

Publication Publication Date Title
FI49035C (fi) Menetelmä terapeuttisesti käytettävän 2-bromi-alfa-ergokryptiinin valm istamiseksi.
FI48460C (fi) Menetelmä farmakologisesti vaikuttavien uusien amino-dihalogeenifenyyl ietyyliamiinien valmistamiseksi.
FI48590C (fi) Menetelmä terapeuttisesti käytettävien atsaspiroalkaanidioniyhdisteide n valmistamiseksi.
FI47364C (fi) Menetelmä terapeuttisesti arvokkaiden 3-indolyyli-alifaattinen-happoyh disteiden valmistamiseksi.
FI49290C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten benseenijohdannaiste n valmistamiseksi.
FI49512C (fi) Menetelmä uusien terapeuttisesti aktiivisten s-triatsinyylipiperatsiin ijohdannaisten valmistamiseksi.
FI50334C (fi) Menetelmä 1-hydroksi-2pyridonien valmistamiseksi.
FI47365C (fi) Menetelmä valmistaa uusia terapeuttisesti vaikuttavia indolijohdannais ia.
FI49971C (fi) Menetelmä mikrobeja tuhoavien 2-nitrofurfurylideeni-indanonijohdannais ten valmistamiseksi.
FI47575C (fi) Analogiamenetelmä evomonosidi-johdannaisten valmistamiseksi.
FI45041C (fi) Menetelmä terapeuttisesti käyttökelpoisten pyrroli-johdannaisten valmi stamiseksi.
FI45551C (fi) Menetelmä terapeuttisesti käytettävän dehydroepiandrosteroniönantaatin valmistamiseksi.
FI44622C (fi) Menetelmä terapeuttisesti arvokkaiden substituoitujen naftaleenijohdan naisten valmistamiseksi.
FI47489C (fi) Menetelmä tulehduksia ehkäisevien 5-(1-aroyyli-3-indolyyli-metyyli)-te tratsolien valmistamiseksi.
FI50975C (fi) Menetelmä pyratsiiniamidi-johdannaisten valmistamiseksi.
FI46727C (fi) Menetelmä pyridatsolijohdannaisten valmistamiseksi.
FI47763C (fi) Menetelmä uusien neriifoliini-johdannaisten valmistamiseksi.
FI52577C (fi) Menetelmä terapeuttisesti käytettävien fenatsiinijohdannaisten valmist amiseksi.
FI48088C (fi) Menetelmä 5-fenyyli-1H-1,4-bentsodiatsepiini-johdannaisten valmistamis eksi
FI45045C (fi) Menetelmä uusien terapeuttisesti vaikuttavien 5-nitro-2-furyyli-isoksa tsolijohdannaisten valmistamiseksi.
FI52088C (fi) Menetelmä 3-(4-asyylioksialkyyli-1-piperatsinyyli)-karbonyylimetyyli-2 -bentsotiatsolinonijohdannaisten valmistamiseksi.
FI48190C (fi) Menetelmä terapeuttisesti aktiivisten 10alfa-metoksi-9,10-dihydroergol iinijohdannaisten valmistamiseksi
FI47358C (fi) Menetelmä terapeuttisesti käytettävän 4'-demetyyli-epipodofyllotoksiin i-beta-D-glukosidin valmistamiseksi.
FI49162C (fi) Menetelmä terapeuttisesti käytettävien 3-indolyyli-alifaattinen-happo- johdannaisten valmistamiseksi.
FI51811C (fi) Menetelmä uusien terapeuttisesti käytettävien 2-okso-7-bentsoyyli-2,3- dihydrobentsofurfaanijohdannaisten valmistamiseksi